SAN FRANCISCO, April 9, 2018 /PRNewswire/ --
The global controlled release drug delivery market size isexpected to reach USD 90.18 billion by 2025, according to a new report by Grand View Research, Inc., registering a 13.8% CAGR during the forecast period. Some of the key factors accelerating market growth are need for alternative
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
Controlled release drug delivery technologies offer various benefits over traditional medication delivery methods. Reduced dosage, lower dosage frequency, fewer adverse gastrointestinal effects, enhanced patient compliance, uniform drug effect, improved efficacy and safety of medication, and reduction in fluctuation of plasma drug levels are some of the benefits offered by these technologies. With an increase in R&D by various pharmaceutical companies, there has been a rise in adoption of these systems.
The North American region accounted for the largest market revenue share due to technologically advanced infrastructure, increasing R&D, and presence of major players and pharmaceutical companies in the region. The Asia Pacific region is anticipated to register the highest CAGR during the forecast period. Emerging countries such as China and India are expected to witness strong growth through 2025 owing to adoption of enhanced healthcare infrastructure and medical technologies for specialized patient care.
Browse full research report with TOC on "Controlled Release Drug Delivery Market Analysis Report By Technology (Transdermal, Microencapsulation, Targeted Delivery), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/controlled-release-drug-delivery-market
Further Key Findings From the Report Suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the global controlled release drug delivery market on the basis of technology, release mechanism, application, and region:
Read Our Blog By Grand View Research: https://www.grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...View All